Canadian Pharmacists Association
Canadian Pharmacists Association

Supply challenges affecting children's pain and fever medications

Canada has been experiencing supply issues affecting pediatric formulations of both acetaminophen and ibuprofen products. The current lack of availability of these products is being driven by significantly increased demand due to a surge in respiratory illnesses across the country. 

As of November 29, over 1.1 million bottles of children’s pain and fever medications have been imported into Canada to help meet the soaring demand. This is helping to supplement the production of Canadian supply, which is at a record high, with some companies producing about 100% more than they were at the same time in 2021.

CPhA has been involved in regular discussions with Health Canada and other key stakeholders to help address the situation and represent pharmacy professionals. We've compiled a number of resources on this page to help support pharmacy teams as they manage this shortage across Canada.

Recomendation for pharmacy professionals: We encourage pharmacies to consider placing temporary limits on purchases of these products (e.g., one product per purchase/customer) where appropriate, to help ensure availability for all who require these medications.

Information and resources

Last updated: December 1, 2022